Investor
FT Global Pharma and Biotech Summit
A high level business summit addressing pharmaceutical commercial strategies, investment, and market access.
- When
- November, Early November
- Where
- London, United Kingdom
- Format
- Hybrid
- Organiser
- Financial Times
- Region
- Global
- Scale
- About 800 attendees
- Founded
- 2000
The briefing
Hosted by the Financial Times, this summit is a premier business meeting for the global pharmaceutical sector. It convenes chief executives, policy makers, and investment bankers to discuss drug pricing, regulatory shifts, and commercialization pipelines. The agenda focuses on the macroeconomic factors shaping life science investment, including intellectual property policy and pricing legislation. It is crucial for life science investors and biotech founders planning commercial scaling.
What to expect
- Drug pricing reform debates
- Pharmaceutical M and A projections
- Geopolitical supply chain strategies
- Biotech financing market outlooks
Who is in the room
Pharmaceutical CEOs, investment bankers, healthcare policy makers, and biotech founders.
Background
The summit has tracked the transformation of the pharmaceutical industry from small molecule blockbusters to advanced biotherapeutics and digital companions. It has maintained its position as a leading venue for strategic financial debate.
Related events
Running this event, or spotted something out of date?